Timothy Alexander

Vertex Announces CEO Transition as David DeStefano Retires, Christopher Young Named Successor KING OF PRUSSIA, PA — Vertex, Inc. (NASDAQ: VERX) announced that President and Chief Executive Officer David DeStefano will retire from his role on N […]

Mineralys Therapeutics to Present Key Lorundrostat Data at ASN Kidney Week 2025 RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) announced that new data from its Phase 2 Explore-CKD trial evaluating lorundrostat in p […]

InterDigital Expands Licensing Portfolio With Sharp Renewal and New EV Charging Deal WILMINGTON, DE — InterDigital, Inc. (Nasdaq: IDCC) announced two key licensing agreements that extend the reach of its intellectual property p […]

West Chester Pushes for a Guinness World Record — and a Cause That Serves Veterans WEST CHESTER, PA — This November, Gage Strength Training will turn determination into philanthropy as the community attempts to break the Guinness W […]

Verrica Pharmaceuticals Gains CHMP Support for YCANTH® Marketing Application in Europe WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that the Committee for Medicinal Products for Human Use (CHMP) of the E […]

Alterra IOS Reports Strong Leasing Momentum Across 21 States in 2025 PHILADELPHIA, PA — Alterra IOS announced a surge in leasing activity across its portfolio during the second and third quarters of 2025, signing 30 n […]

Kim Groves Named 2025 Goddard School Director of the Year for Leadership and Educational Excellence KING OF PRUSSIA, PA — Goddard Systems, LLC, the manager of The Goddard School® franchise network, has named Kim Groves as the 2025 Goddard School Di […]

STRATA Skin Sciences Strengthens Market Position Following Court Rulings in False Advertising Case HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced new progress in its litigation against LaserOptek America Corp., LaserOptek Co. L […]

ENHERTU Combination Shows Promising Results in Early Breast Cancer Trial WILMINGTON, DE — AstraZeneca and Daiichi Sankyo reported that their antibody-drug conjugate ENHERTU® (fam-trastuzumab deruxtecan-nxki), when used be […]

Levitask Unveils Patent-Pending T-Mech Mechanism, Introducing New Era of Elevated Seating WILMINGTON, DE — Levitask has announced the development of its patent-pending T-Mech mechanism, an ergonomic innovation designed to bridge the gap b […]

AstraZeneca and Amgen Secure FDA Approval for TEZSPIRE to Treat Chronic Rhinosinusitis with Nasal Polyps WILMINGTON, DE — AstraZeneca and Amgen have received U.S. Food and Drug Administration (FDA) approval for TEZSPIRE® (tezepelumab-ekko) as an add-on ma […]

The Bancorp to Report Third Quarter 2025 Financial Results on October 30 WILMINGTON, DE — The Bancorp, Inc. (NASDAQ: TBBK) announced that it will release its third quarter 2025 financial results after the market closes on T […]

Pennsylvania’s Puppy Mill Problem Persists Despite Years of Promises and Reform Efforts PENNSYLVANIA – Nearly two decades after Pennsylvania vowed to end the state’s notorious “puppy mill” reputation, a new investigation suggests that pr […]

Pennsylvania Among the Nation’s Most Generous Halloween Hosts, Study Finds PENNSYLVANIA — Pennsylvanians are among America’s most generous Halloween hosts, ranking near the top for candy spending and trick-or-treater tur […]

Mid Penn Bank Appoints Eric Murchison as Vice President and Commercial Loan Officer PHILADELPHIA, PA — Mid Penn Bank, a wholly owned subsidiary of Mid Penn Bancorp, Inc. (NASDAQ: MPB), announced the appointment of Eric Murchison as v […]

IMFINZI Combination Cuts Disease Recurrence Risk by 32% in Early Bladder Cancer Trial WILMINGTON, DE — AstraZeneca announced that its IMFINZI (durvalumab) regimen significantly reduced the risk of disease recurrence or death by 32 p […]

Savara Elevates Dr. Yasmine Wasfi to CMO as Autoimmune PAP Program Advances LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) promoted Yasmine Wasfi, M.D., Ph.D., FCCP, to chief medical officer, succeeding Ray Pratt, M.D., FACP, who w […]

AstraZeneca Reports IMFINZI-Based Regimen Cuts Death Risk by 22% in Early Gastric Cancer WILMINGTON, DE — AstraZeneca announced new data from its Phase III MATTERHORN trial showing that its immunotherapy IMFINZI (durvalumab), when used in c […]

Germantown Historical Society Opens ‘American Mythologies,’ a Contemporary Look at the Stories That Shaped the Nation PHILADELPHIA, PA — The Germantown Historical Society has unveiled American Mythologies, a new exhibition featuring the work of Philadelphia-based a […]

Chemours to Release Third-Quarter 2025 Financial Results on November 6 WILMINGTON, DE — The Chemours Company (NYSE: CC) announced that it will release its third-quarter 2025 financial results after the market closes on T […]